QIREXYNOR. BUILT FOR THE MOMENTS THAT MATTER.

Intellectual property

TACTICAL ASSET PROTECTION PROTOCOL

All intellectual property (IP) associated with Qirexynor—including patents, trademarks, copyrights, and trade secrets—constitutes our Proprietary Operational Assets. These assets are protected by U.S. and international IP laws. Unauthorized exploitation will be met with swift legal action.

1. PATENT-PENDING TECHNOLOGY (CORE INVENTIONS)

Our flagship innovations are shielded by pending patents:
  • Qen One-Handed Tourniquet: Protected under U.S. Patent Application Nos. [Insert Numbers, e.g., 29/123,456]. This covers the unique windlass mechanism, single-handed application geometry, and TIME-label integration.
  • IFAK Modular Systems: Proprietary MOLLE-compatible pouch configurations and internal organization layouts are patent-pending.
  • Design Innovations: The distinctive ornamental designs of our gear (e.g., color-blocking, strap routing, buckle shapes) are protected under Design Patent Applications.
  • Warning: Manufacturing, importing, selling, or using knockoffs of Qirexynor’s patented technology constitutes infringement. We actively monitor global marketplaces and trade shows for violations.

2. TRADEMARKS & BRAND IDENTITY (DISTINCTIVE SIGNS)

The following marks are registered or common-law trademarks of Qirexynor:
  • Word Marks: QIREXYNOR™, QEN™, "Engineered for Moments That Matter Most"™
  • Design Marks: Our logo (stylized "Q" with tactical striping), product silhouettes, and distinctive color schemes (e.g., matte black with #9d0a0e accents).
  • Service Marks: "Secure Intel Handling Protocol"® (for data protection services).
  • Prohibition: Do not use Qirexynor marks without prior written consent. This includes:
    • Incorporating marks into product listings (e.g., "compatible with Qirexynor").
    • Using marks in domain names, social media handles, or advertising keywords.
    • Altering marks (e.g., changing colors, distorting logos).
  • Fair Use Exception: Media outlets may use marks in news reporting with proper attribution (e.g., "Qirexynor tourniquets deployed in disaster relief").

3. COPYRIGHTED CONTENT (CREATIVE WORKS)

All content on Qirexynor.com and our marketing materials is protected by U.S. Copyright Law (© 2026 Qirexynor):
  • Website Content: Text (product descriptions, blogs, policies), graphics, icons, UI/UX layouts, and code.
  • Visual Media: Product photography, training videos, 3D renderings, and infographics.
  • Marketing Collateral: Catalogs, brochures, email templates, and social media posts.
  • Restrictions: Do not reproduce, distribute, or create derivative works without express permission. Limited personal use (e.g., downloading a product manual for private training) is permitted.

4. TRADE SECRETS (CONFIDENTIAL INTEL)

Certain operational data remains strictly confidential:
  • Manufacturing Processes: Proprietary stitching patterns, material sourcing, and quality-control protocols.
  • Supplier Networks: Names and locations of vetted vendors and logistics partners.
  • Internal Algorithms: Sales forecasting models, customer segmentation data, and pricing strategies.
  • Non-Disclosure Agreements (NDAs): Employees, contractors, and distributors are bound by NDAs to protect this intel. Unauthorized disclosure will result in legal penalties.

5. COUNTERFEIT REPORTING HOTLINE

Encountered fake Qirexynor gear? Help us protect lives:
  • Report Suspected Infringement: Email Support@Qirexynor.com with:
    • Seller name/platform (e.g., Amazon storefront, Instagram ad).
    • Product listing URL or screenshots.
    • Photos of counterfeit gear (highlight differences from authentic products).
    • Purchase date/order number (if applicable).
  • Our Enforcement Actions:
    • Issue cease-and-desist letters to infringers.
    • File takedown requests with platforms (e.g., Amazon Brand Registry, eBay VeRO).
    • Initiate civil litigation for damages (including confiscation of counterfeit inventory).
    • Collaborate with U.S. Customs and Border Protection (CBP) to seize imports at ports of entry.

6. LIMITED LICENSE FOR DISTRIBUTORS

Authorized distributors may use Qirexynor IP solely to promote genuine products:
  • Permitted Uses: Displaying trademarks on websites, printing logos on marketing flyers, embedding official product videos.
  • Restrictions: No modifying assets, no sublicensing to third parties, and no use after termination of distribution agreements.
  • Quality Control: All marketing materials must adhere to Qirexynor’s Brand Style Guide (available upon request).

7. DMCA COMPLIANCE (DIGITAL COPYRIGHT)

For copyright infringement claims on our website or hosted content:
  • Notice Requirements: Submit a DMCA Takedown Notice to Support@Qirexynor.com including:
    • Physical/digital signature of the copyright owner.
    • Description of the copyrighted work.
    • URL of infringing material on our site.
    • Your contact information.
    • Statement of good-faith belief that use is unauthorized.
  • Counter-Notice: If you believe content was wrongly removed, submit a counter-notice—we will restore content if valid.

8. GOVERNING LAW & JURISDICTION

IP disputes are governed by:
  • U.S. Federal Law: Lanham Act (trademarks), Patent Act, Copyright Act.
  • State Law: Delaware Uniform Trade Secrets Act (DUTSA).
  • Venue: Federal District Court for the District of Delaware (or state courts in New Castle County).
  • International Treaties: Paris Convention, Berne Convention, TRIPS Agreement.

9. CONTACT THE IP DESK

Questions about licensing? Need permission to use assets?
Report infringement or request authorization at Support@Qirexynor.com
We respond to all IP inquiries within 48 business hours.